Table 6:
Subgroup analysis by treatment technique
| Overall | Aspirin+Clopidogrel Group | Aspirin+Ticagrelor Group | P Value | |
|---|---|---|---|---|
| Nonavailable data | 1 | 1 | 0 | |
| Stent-assisted coiling (%) | 100 | 56 (56.0) | 44a (44.0) | |
| Primary outcome (%) | 10 (10.0) | 6 (10.7) | 4 (9.1) | >.999 |
| Secondary outcomes (%) | ||||
| Ischemic stroke | 6 (6.0) | 3 (5.4) | 3 (6.8) | >.999 |
| Disabling stroke | 2 (2.0) | 1 (1.8) | 1 (2.3) | >.999 |
| Any death | 2 (2.0) | 2 (3.6) | 0 | .502 |
| Safety outcome (%) | 9 (9.0) | 7 (12.5) | 2 (4.5) | .292 |
| Flow-diverter (%) | 135 | 86b (60.6) | 49 (52.7) | |
| Primary outcome (%) | 12 (8.9) | 8 (9.3) | 4 (8.2) | >.999 |
| Secondary outcomes (%) | ||||
| Ischemic stroke | 11 (8.1) | 7 (8.1) | 4 (8.2) | >.999 |
| Disabling stroke | 6 (4.4) | 3 (3.5) | 3 (6.1) | .668 |
| Any death | 2 (1.5) | 1 (1.2) | 1 (2.0) | >.999 |
| Safety outcome (%) | 10 (7.4) | 6 (7.0) | 4 (8.2) | >.999 |
a
Including 2 salvage therapies for coil protrusion and Pipeline flow-diverter migration.
b
Including 1 salvage therapy for poor wall apposition of Surpass.